Skip to main content
SpringerLink
Log in

Drospirenone-containing OCs under review for VTE

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.FDA Drug Safety Communication: Safety Review of possible increased risk of blood clots with birth control pills containing drospirenone Internet Document: [1 page], 1 Jun 2011. Available from: URL: http://www.fda.gov

  2. EMA.Pharmacovigilance Working Party (PhVWP) - May 2011 plenary meeting Internet Document: [6 pages], 1 Jun 2011. Available from: URL: http://www.ema.europa.eu

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drospirenone-containing OCs under review for VTE. React. Wkly. 1355, 2 (2011). https://doi.org/10.2165/00128415-201113550-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113550-00002

Keywords

Search

Navigation